Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-18

FDA Approved: NIFEDIPINE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals Inc.'s nifedipine under an original ANDA, authorizing a generic nifedipine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)

Snippet

ORIG AP for NIFEDIPINE (NIFEDIPINE)